| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.02 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.069 | 0.02 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |